Latest news
Before surgery, Multikine cut disease-progression risk 49% in study - Stock TitanStock Titan · Tue, 04 Aug 2026 12:00:00 GMTLeading Oncology Journal Accepts For Publication New CEL-SCI Multikine Phase 3 Data Demonstrating Overall Survival Benefit in Underserved Head and Neck Cancer Patients - Yahoo FinanceYahoo Finance · Thu, 30 Jul 2026 07:00:00 GMT